Medical - Marijuana Law Group
In response to New York’s passage of the Compassionate Care Act (CCA), Abrams Fensterman launched the Medical Marijuana Law Group, a suite of integrated legal services that efficiently and effectively address the myriad legal needs of the burgeoning medical marijuana industry.
Lead by a team of senior attorneys who, on their own, are of the most well regarded professionals in their respective fields, the Medical Marijuana Law Group delivers a unique array of comprehensive, sophisticated and robust legal services that are increasingly important to those involved in the legal marijuana business.
Our expertise in healthcare regulation, business formation, financing, mergers & acquisitions, investment fund formation, licensing, employment and civil/criminal litigation can be accessed individually or in unique combinations by clients who are directly involved or simply interfacing with various aspects of the medical marijuana industry.
The Medical Marijuana Law Group is led by Michael Bass, Esq. and Richard Thomas, Esq. Specifically, we counsel clients on a full range of medical- marijuana related matters, including:
Our attorneys have presented at professional and educational conferences, authored publications and been quoted by the press and media on the subject.
For further information about how our attorneys can help you navigate the complex legal issues of the medical-marijuana industry, please contact our law firm on Long Island at 516-328-2300, in Brooklyn at 718-215-3000, Manhattan at 212-279-9200, White Plains at 914-607-7010, Rochester at 585-218-9999 or Albany at 518-535-9477 to schedule an initial consultation.